human cytomegalovirus immunoglobulin

Poland

Drugs containing this active substance

  • MEGALOTECT CP

    The medicine is administered to patients receiving immunosuppressive treatment (suppressing the immune system) to prevent symptoms of cytomegalovirus infection, especially in organ transplant recipients.

    Form: solution for infusion

    Active substance Dosage
    human cytomegalovirus immunoglobulin 100 U/ml

    ATC: J06BB09

    Manufacturer: Biotest Pharma GmbH